艾伯维Abbvie Inc (ABBV) 2014年年度报告「NYSE」.pdf

1、AbbVie1 North Waukegan Road North Chicago,IL 60064 U.S.ACopyright 2015 AbbVie.All rights reserved.2014 annual report on form 10-k2015 notice of annual meeting and proxy statement2200_Cover.indd 13/11/15 3:15 PMabout abbvieAbbVie is a global,research-basedbiopharmaceutical company formedin 2013 follo

2、wing separation fromAbbott Laboratories.The companysmission is to use its expertise,dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the worlds most complex and serious diseases.AbbVie employs more than 26,000 people worldwide and marke

3、ts medicines in more than 170 countries.For further information on the companyand its people,portfolio and commitments,please visit .stockholder informationAbbVie Inc.Corporate Headquarters1 North Waukegan RoadNorth Chicago,IL Investor RelationsDept.ZZ05,AP34Corporate SecretaryDept.V364,AP34Stock Li

4、stingThe ticker for AbbVies common stockis ABBV.The principal market for AbbViecommon stock is the NYSE.AbbViecommon stock is also listed on the ChicagoStock Exchange,the NYSE Euronext Paris,and the SIX Swiss Exchange.Annual MeetingThe Annual Meeting will be held on Friday,May 8,2015,at 9 a.m.at the

5、 Fairmont Chicago,Millennium Park,200 North Columbus Drive,Chicago,IL 60601.Dividend Reinvestment PlanThe AbbVie Dividend ReinvestmentPlan offers registered stockholdersan opportunity to purchase additionalshares,commission-free,throughautomatic dividend reinvestmentand/or optional cash investments.

6、Interested persons may contact thetransfer agent.Transfer AgentComputershare Trust Co.NAP.O.Box 43078Providence,RI 02940-3078877.881.5970(toll free)2200_Cover.indd 23/11/15 3:15 PM13NOV201221365766Dear AbbVie Shareholder:When AbbVie launched as a new company in January of 2013,our stated goal was to